John Pavlidis, President & CEO

John Pavlidis joined Estech in October 2008. Prior to that, he was President and CEO of R2 Technology Inc., the pioneer and leader in Computer Aided Detection of breast cancer and lung abnormalities. At R2 Pavlidis led the turnaround of the business, formed a new senior management team and implemented new processes and discipline for profitable growth. The company was acquired for $225 million in 2006 by Hologic, Inc., the leader in women’s health. From 2000 until 2004 Pavlidis was the president of the Siemens Ultrasound business worldwide. Pavlidis led the ultrasound business through significant restructuring and growth including the acquisition of USA market leader Acuson Corporation, expansion of R&D and manufacturing in Asia and market introduction of numerous products and upgrades. Siemens Ultrasound had reached revenues approaching $1 billion at the time of his departure. Pavlidis holds a master’s degree in Engineering Sciences from Dartmouth College in Hanover, New Hampshire and a bachelor’s degree in Biomedical Engineering from Rensselaer Polytechnic Institute in Troy, New York.

Terry Kinninger, CFO & COO

Terry Kinninger has over 25 years of executive experience managing venture capital backed medical device and technology companies both NASDAQ publicly traded and privately held. He has held diverse executive responsibilities and has participated in raising more than $200M through IPOs, venture capital and debt financings. Terry also has significant M&A experience completing more than a dozen transactions representing acquirers or sellers, totaling over $600 million in value. More recently, Mr. Kinninger was CFO & Executive VP Business Development of R2 Technology, a medical device company. Mr. Kinninger has also served as COO & CFO of Bridge Medical; CFO & Senior VP Operations of MetaCreations; CFO, Senior VP Corporate Development & GM of Delphi Information Systems; CFO & VP Administration of Integral Systems; and CFO of WebSideStory and Imagine Communications. Terry Kinninger holds a BS from Miami University, Ohio and early in his career was a CPA with PricewaterhouseCoopers.

Andrew S. Wechsler, MD

Dr. Andrew S. Wechsler is the Stanley K. Brockman Professor and Chairman of the Department of Cardiothoracic Surgery at Drexel University College of Medicine in Philadelphia, Pennsylvania. He is the Editor Emeritus of the Journal of Thoracic and Cardiovascular Surgery and past Editor in Chief for the American Association for Thoracic Surgery. Dr. Wechsler has served as Chairman of the NIH Surgery and Bioengineering Study section and holds or has held numerous leadership positions in Cardiothoracic Surgical Organizations. Additionally, he has held several NIH grants supporting a career long interest in myocardial ischemia and reperfusion injury, ventricular performance and valve surgery. He is the author or co-author on over 330 peer reviewed manuscripts, 59 book chapters, and 29 books and monographs. He has served on the editorial board of ten major journals and in 2008 was named the seventh recipient of the American Association for Thoracic Surgery Scientific Achievement Award. He currently also serves as a senior advisor to the Division of Cardiovascular Sciences at the National Institute of Health.

David Swanson, Ph.D., Chief Technical Officer

Dr. Swanson joined Estech in August of 2005 as its Chief Technical Officer. Dr. Swanson is an inventor on over 280 patents issued by the US patent office. The San Jose Mercury News has identified him as one of the top 10 inventors in California. Before joining Estech, Dr. Swanson worked for Boston Scientific/EP Technologies for 14 years. While there he held various positions including Senior Director of R&D and Head of Intellectual Property. Previously, Dr. Swanson led the Tachyarrhythmia Research and Technology Group at Cardiac Pacemakers, Inc. Dr. Swanson holds a Ph.D. in Electrical and Computer Engineering and a MS degree in Physiology from the University of Wisconsin at Madison and a B.S. degree in Physics from Northern Illinois University. In 2008, he received the Distinguished Achievement Award from University of Wisconsin – Madison.

Tamer Ibrahim, Vice President, Research & Development / Quality Assurance / Regulatory Affairs

Tamer Ibrahim has been with Estech since April of 2000 and oversees Research & Development, Regulatory Affairs and Quality Assurance. Tamer has lead the development of over 60 cardiac surgery devices within Estech’s core focus areas of RF Ablation, Valve, and CABG and has invented key technology to strengthen Estech’s IP position within each area. He has also managed the development and implementation of Estech’s corporate quality system and helped Estech to become the first company to receive CE mark to market RF ablation products with an indication to treat atrial fibrillation. Previously, Tamer worked at the VA Rehabilitation R&D center, designing implantable devices aimed to advance hip prostheses. Tamer received his M.S. from Stanford in Biomechanical Engineering and B.S. from U.C. Berkeley in Mechanical Engineering and Materials Science Engineering.

Mark Koeniguer, Vice President of Sales and Commercial Operations Worldwide

Mark brings over 20 years of healthcare industry experience in leading roles at emerging as well as established companies. Most recently, Mark was the Chief Operating Officer, North America and EMEA at Ziosoft Inc., a leader in advanced visualization technology. Mark transformed Ziosoft Japan into a global player by building the US and European organizations and developing its marketing, product, and distribution strategies. Prior to Ziosoft Inc., he was the Global Vice President of Sales at R2 Technology, where he restructured the company’s distribution organization resulting in a substantial sales turnaround for the company. Prior to joining R2, Mark was the global Vice President of Sales and Marketing at Stereotaxis, Inc. Mark started his career at GE Healthcare where he was recognized as a six-sigma black belt and held various marketing, sales and finance positions over a 14 year period. Mark holds a Bachelor of Science degree with a major in Finance from the University of Iowa and a Master’s in Business Administration (MBA) from the University of Wisconsin – Madison.

Jean Zartler, Director of Global Marketing